Fibronectin protects lung cancer cells against docetaxel-induced apoptosis by promoting Src and caspase-8 phosphorylation

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells

(2015) Lina Yang et al.   CANCER LETTERS

Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition

(2015) Hiroki Tamaki et al.   Oncotarget

Cancer treatment and survivorship statistics, 2014

(2014) Carol E. DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data

(2014) Antonio Rossi et al.   LANCET ONCOLOGY

Adjuvant treatment in resected non-small cell lung cancer: Current and future issues

(2013) Jordi Remon et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Src Regulates the Activity of the ING1 Tumor Suppressor

(2013) Lisa Yu et al.   PLoS One

From procaspase-8 to caspase-8: Revisiting structural functions of caspase-8

(2010) Yang Zhao et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Cell adhesion to fibronectin induces mitomycin C resistance in bladder cancer cells

(2009) Chun-Wu Pan et al.   BJU INTERNATIONAL

Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion

(2009) X N Meng et al.   BRITISH JOURNAL OF CANCER

Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells

(2008) Hui Xing et al.   CANCER LETTERS